Full Text

Turn on search term navigation

ARTICLE

Received 6 Oct 2014 | Accepted 10 Feb 2015 | Published 25 Mar 2015

Michelle Hong1,2, Elena Sandalova1, Diana Low3, Adam J. Gehring1, Stefania Fieni4, Barbara Amadei5, Simonetta Urbani5, Yap-Seng Chong1,6, Ernesto Guccione3,7 & Antonio Bertoletti1,2,8

The newborn immune system is characterized by an impaired Th1-associated immune response. Hepatitis B virus (HBV) transmitted from infected mothers to newborns is thought to exploit the newborns immune system immaturity by inducing a state of immune tolerance that facilitates HBV persistence. Contrary to this hypothesis, we demonstrate here that HBV exposure in utero triggers a state of trained immunity, characterized by innate immune cell maturation and Th1 development, which in turn enhances the ability of cord blood immune cells to respond to bacterial infection in vitro. These training effects are associated with an alteration of the cytokine environment characterized by low IL-10 and, in most cases, high IL-12p40 and IFN-a2. Our data uncover a potentially symbiotic relationship between HBV and its natural host, and highlight the plasticity of the fetal immune system following viral exposure in utero.

DOI: 10.1038/ncomms7588 OPEN

Trained immunity in newborn infants of HBV-infected mothers

1 Singapore Institute for Clinical Sciences, Agency for Science, Technology and Research (A*STAR), 30 Medical Drive, Singapore 117609, Singapore.

2 Emerging Infectious Diseases (EID) Program, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore. 3 Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore 138673, Singapore. 4 UOC Ostetricia e Ginecologia, Dipartimento Materno Infantile, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy. 5 UO Immunoematologia e Medicina Trasfusionale, Dipartimento Diagnostico, Azienda Ospedaliero-Universitaria di Parma, Via Gramsci 14, 43126 Parma, Italy. 6 Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, National University Health System, 1E Kent Ridge Road, Singapore 119228, Singapore.

7 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Block MD 7, 8 Medical Drive, Singapore 117597, Singapore.

8 School of Immunity and Infection, College of Medical and Dental Science, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Correspondence and requests for materials should be addressed to A.B. (email:mailto:[email protected]

Web End [email protected] ).

NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 1

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588

Infants have higher susceptibility to severe infections than adults due to functional differences in their immune system1,2. Hepatitis B virus (HBV) infection is a serious global health

problem that causes liver inammation and cancer in chronically infected adults3. As a large part of HBV chronic infections are acquired at birth, HBV is viewed as the prototypical pathogen that is thought to hijack the immaturity of the neonatal immune system and to establish a persistent infection through the induction of an immunotolerant state in the host. Data from experimental animal models (that is, HBV-transgenic mice) showing the presence of immunological defects that impair T- and B-cell priming46 support this scenario.

However, the dogma of immune defects induced by HBV is at odds with the efcacy of HBV vaccination in infants born to HBV mothers4 and with observations obtained in malaria-HBV co-infected young subjects in whom reduced parasitemia7 and an increased incidence of cerebral malaria, a T-helper (Th)1-mediated malaria complication8,9, were reported. Recent data have also shown that chronically HBV-infected adolescents labelled as immunotolerant do not display any tolerogenic T-cell features10.

In addition to these inconsistencies between experimental data in HBV models and data obtained during natural infection, there is an increased recognition that the neonatal immune system is not defective11. Instead, it presents unique functional features1113 and the functional maturation of neonatal immunity can be modulated by external factors. For example, bacterial colonization and vaccinations with live vaccines can decrease infant mortality and protect them against unrelated pathogens by inducing an increased functional efciency of their innate immune system that has been termed trained immunity14,15.

To directly characterize the impact of HBV exposure on the newborn immune system, we performed a comprehensive immunological analysis of the cord blood (CB) cells from neonates of HBV chronically infected mothers. We report that HBV exposure in utero does not induce generic immunological defects but, on the contrary, is associated with a mature immunological prole that enhances the ability of the neonatal immune cells to respond to unrelated pathogens in vitro.

ResultsCytokine prole in HBV-exposed CB. We rst analysed the cytokine prole of the umbilical CB plasma of HBV-exposed and healthy unexposed neonates of Asian origin (refer list of subject materials in Supplementary Table 1). The production of immunosuppressive cytokine (interleukin (IL)-10) was minimal (o10 pg ml 1) and signicantly lower in the CB plasma of HBV mothers than controls (means.e.m. in pg ml 1;

healthy, 9.64.2, HBV, 1.30.7; Fig. 1a), whereas Th2 cytokines (IL-4, IL-5, IL-9 and IL-13) and pro-inammatory cytokines (IL-1a and IL-1b) were undetectable in the CB plasma of HBV mothers and healthy controls (Supplementary Fig. 1). On the contrary, neonates born to HBV mothers had signicantly higher plasma concentration of innate anti-viral cytokines

IL-12p40 and interferon-a2a (IFN-a2) than healthy controls (means.e.m. in pg ml 1; IL-12p40: 56.714.2 versus 185;

IFN-a2: 137.328.1 versus 48.43.8; Fig. 1a). The presence of pro-inammatory cytokines (IL-6, IL-8 and tumour necrosis factor-a (TNF-a)), anti-inammatory cytokine (IL-1ra), Th17-related cytokine (IL-17) and neutrophil-related chemokines and growth factors (eotaxin, granulocyte-colony stimulating factor, granulocyte macrophage-colony stimulating factor and growth-regulated oncogene (GRO)) was instead signicantly lower in the CB plasma of neonates of HBV mothers than controls (Fig. 1a).

No difference was observed in the plasma levels of monocyte- and

T-cell-attracting chemokines (MCP-1, MDC, MIP-1a, MIP-1b, Rantes; Supplementary Fig. 1). The elevated levels of IL-12p40 and IFN-a2 in the majority of the CB plasma in neonates born to

HBV Asian mothers were unexpected, as the production of these cytokines are often low or undetectable both during acute

HBV infection16 and during chronic HBV reactivation in adults17.

Importantly, we conrm this unique cytokine pattern (high IL-12p40 and low IL-10) in an independent cohort of CB samples from Caucasian HBV mothers (refer Supplementary Table 1 and Supplementary Fig. 2a,b). HBV-exposed CB plasma had increased IFN-a2 compared with healthy controls, although this difference was not statistically signicant. The production of the pro-inammatory cytokine IL-6 was minimal (o5 pg ml 1) and no difference was observed in the level of TNF-a. Nevertheless, HBV-exposed neonates of Caucasian HBV mothers showed decreased production of IL-8 in their CB plasma than controls, even though it was not statistically signicant (Supplementary Fig. 2a). As type-III IFN was recently reported as an innate antiviral factor produced by human primary hepatocytes in response to HBV infection18, we tested the production of IFN-l together with other type-I IFN (that is, IFN-b) in the CB plasma. Our data showed that although IFN-b was undetectable in all the CB plasma of both Asian and Caucasian cohorts, IFN-l was only detectable in 1 out of 18 HBV-exposed CB plasma (Supplementary Figs 1 and 2a).

IL-12p40 has been reported to act either as a single cytokine or as a component of IL-23 or IL-12p70 (ref. 19), but we detected modest level of IL-12p70 (means.e.m. in pg ml 1; healthy,6.81.4, HBV, 6.50.1) and the absence of IL-23 in the CB plasma of neonates from HBV mothers (Supplementary Fig. 1), suggesting that IL-12p40 in the CB was present as a single agonistic cytokine19. Furthermore, we estimated the ratio of IL-12p70/IL-10 as an indication of a Th1/Th2 balance. Our data showed a signicantly higher ratio of IL-12p70/IL-10 in HBV-exposed CB plasma than controls (means.e.m. ratio; HBV, 4.32.9, healthy, 0.90.2) (Fig. 1b). This shift in Th1 cytokine balance was also observed in the independent cohort of CB samples from neonates of Caucasian HBV mothers (Supplementary Fig. 2b).

HBV exposure in utero enhances innate immune activation. The detection of elevated levels of IL-12p40, combined with the detection of low IL-10 and Th2 cytokines, does not support the hypothesis that HBV induces a state of immune tolerance in newborns. Furthermore, elevated levels of IL-12p40 has been associated with sepsis control in newborns20, suggesting that this cytokine might be linked with increased immunological maturity. Therefore, we rst analysed the frequency of different antigen-presenting cells (APCs) in HBV-exposed and healthy CB (Supplementary Fig. 3). The frequency of total APCs (or HLADR cells) and of the various APC subsets was not affected by

HBV exposure in utero.

In contrast, the functional prole of CD14 monocytes, the most abundant population of innate immune cells present in the

CB, is signicantly different in HBV-exposed CB as compared with healthy controls. CD14 monocytes were sorted directly ex vivo from the CB of healthy (n 4) or HBV Asian mothers

(n 3; 2 HBeAg , 1 HBeAg; refer Supplementary Table 1),

and were analysed for the expression of 511 immune genes with Nanostring technology21. There were no signicant differences in immune gene prole between CB monocytes of HBeAg and

HBeAg mothers, but notably a total of 400 immune genes were differentially expressed between HBV-exposed and healthy CB monocytes (Fig. 2a). Non-supervised hierarchical clustering

2 NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588 ARTICLE

Suppressive

Anti-viral

Th17 IL-17

IL-10 IL-12p40 IFN-2

150

100

pg ml1

400

300

pg ml1

****

pg ml1

200

100

0 Healthy

IL-6 IL-8 TNF- IL-1ra

HBV HBV

0 Healthy Healthy HBV

0 Healthy

HBV

Pro-inflammatory Anti-inflammatory

Chemokines/growth factors

400 300

0 0

*** **

1,500

1,000

500

pg ml1

200 100

pg ml1

200 100

60 40 20

pg ml1

0 Healthy

HBV

0 Healthy

HBV

Healthy HBV

Healthy

HBV

Eotaxin

G-CSF

IL-12p70/IL-10 ratio

GM-CSF

GRO

1,000

5,000

* ***

8,000

800

4,000

6,000

600

3,000

pg ml1

4,000

400

2,000

200

1,000

2,000

0 Healthy

HBV

0 Healthy

HBV

0 Healthy

Th1/Th2 cytokine ratio

HBV

0 Healthy

HBV

Figure 1 | High levels of IL-12p40 and IFN-a2, and low levels of IL-10 and pro-inammatory cytokines in the CB of Asian HBV mothers.(a) CB plasma cytokines were determined by multiplex assay in seven healthy controls and ten HBV mothers. Horizontal line represents the median.

(b) Ratio of Th1/Th2 cytokine (IL-12p70/IL-10) in healthy and HBV-exposed CB. P-values were calculated using MannWhitney test. *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001.

showed six gene clusters corresponding to genes uniquely upregulated in healthy (cluster I, n 104) and HBV-exposed

(cluster III, IV and V, n 8, n 195 and n 47, respectively) CB

monocytes, as well as genes that were not distinctly enriched in either populations (cluster II and VI, n 32 and n 14,

respectively) (Fig. 2a).

The differentially expressed genes between healthy and HBV-exposed CB monocytes can be broadly grouped into six different gene categories (Fig. 2b). Specically, HBV-exposed CB monocytes expressed higher levels of messenger RNA associated with major histocompatibility complex class II processing and presentation, complement components, Th1-related cytokines (including IL-12p40 encoded by the mRNA IL12B, IFN-a2,

IFN-g and IL-15) and signalling molecules (Fig. 2b and Supplementary Table 2). Furthermore, the chemokine CXCL13, whose defect in HBV transgenic models has been recently

suggested to predispose to HBV chronicity6, was signicantly upregulated in HBV-exposed CB monocytes (Fig. 2c). On the other hand, the mRNA expression of pro-inammatory cytokines (IL-1b, IL-6, IL-8 and TNF-a) was lower in HBV-exposed

CB monocytes than healthy CB monocytes (Fig. 2b and Supplementary Table 2), further conrming the plasma cytokine data (Fig. 1a). Interestingly, the immune gene prole of HBV-exposed CB monocytes was more similar to the immune prole of healthy adult peripheral blood monocytes than that of the control CB monocytes, suggesting an increased immune maturation state of HBV-exposed CB monocytes (Fig. 2a,b). In addition, analysis of IFN-stimulated gene (ISG) expression revealed signicant increase in the expression of several ISGs in HBV-exposed CB monocytes than controls (Supplementary Fig. 4), in line with the enhanced production of IFN-a2 in this cohort of HBV-exposed CB plasma (Fig. 1a).

NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 3

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588

Complenent components

P=0.06

Chemokines and receptors

I V

III

Normalized counts

100,000

100

****

CIITA C1S

C4B

C1QA

C1QB

CFB

CCL15

CCL3

CCL4

CCR2

CCR5

CXCL1

CXCL13

CXCL2

CXCR4

IL6

IL8

IL1A IL1B

IL1R2 IL1RAP

IL1RN

TNF

Normalized counts

Healthy

10,000

1,000

HBV

Adult

HLA-DQA1

HLA-DQB1

HLA-DRA

HLA-DRB1

HLA-DRB3

HLA-DPA1

HLA-DPB1

Normalized counts

100,000

10,000

1,000

100

High

Low

Healthy

100 HBV

Adult

Healthy

HBV

Adult

Healthy

1 HBV

Adult

No. of

Expression genes

Cluster level

I II III IV

V VI

Representative gene categories

Cytokines and receptors

Signaling molecules Pro-inflammatory cytokines

104

8 195

47 14

HBV < Healthy

Regulation of apoptosis

Pro-inflammatory cytokines

****

IRAK1

Normalized counts

****

IRAK4

IRF3

IRF5

IKBAP

IKBKB

IKBKG

MAP4K1

MAP4K2

MAP4K4

STAT2

TRAF6

STAT5A

100,000

Ag processing and presentation, complement

activation, chemokines, cytokines, signaling molecules

MHC class II processing

and presentation

1,000

100 1,000

100

IFNA2

IFNG

IL10

IL12A

IL12B

IL12RB1

IL15

LTA

TNFSF11

TNFSF8

TNFRSF17

1,000,000

10,000

1,000

100

HBV > Healthy

Normalized counts

HBV = Healthy

HBV > Healthy

Chemokines, cytokines

HBV = Healthy

Healthy

1 HBV

Adult

Healthy

HBV

Adult

Healthy

10 HBV

Adult

CXCL13

IL-12p40

80 4.54.03.53.02.52.0

Normalized counts

HLA-DR MFI

500 1,000

800 600 400 200

400 300 200 100

20,000

15,000

10,000

5,000

Proliferation index

pg ml1

CD40 MFI

CD80/CD86 MFI

Healthy

HBV

Adult

Healthy

HBV

Healthy

0 HBV

Healthy

0 HBV

Healthy

0 HBV

Healthy

HBV

Figure 2 | HBV exposure in utero enhances CB CD14 monocyte maturation and activation. (a) Immune gene proling on sorted CD14 monocytes performed using Nanostring technology. Non-supervised hierarchical clustering of the expression of 400 immune-related genes differentially expressed between CD14 monocytes from healthy (Healthy, n 4) and HBV-exposed (HBV, n 3) CB. CD14 monocytes from healthy adult peripheral blood

mononuclear cells (PBMCs; Adult, n 3) were included for comparison. Table shows the comparative mRNA levels, number of genes and representative

gene categories in each gene cluster. (b) The differentially expressed genes between healthy and HBV-exposed CB monocytes can be broadly grouped into six gene categories. Graphs show the mean mRNA expression (in Nanostring counts) for representative immune genes in monocytes of healthy CB, HBV-exposed CB and adult peripheral blood within these six different gene categories. P-values between healthy and HBV-exposed CB were calculated using two-way analysis of variance with Bonferronis post test (refer to Supplementary Table 2). (c) The mRNA expression (in Nanostring counts) of the chemokine CXCL13 in monocytes measured with Nanostring technology. (d) Sorted CD14 monocytes from healthy (n 4) and HBV-exposed (n 3) CB

were incubated with 1 mg ml 1 ssRNA40 (TLR8 agonist) for 18 h and IL-12p40 in the supernatant measured using luminex. Data show means.e.m. of each group. (e) The median uorescence intensity (MFI) expression of HLA-DR, CD40 and CD80/CD86 on CD14 monocytes from healthy (n 5) and

HBV-exposed (n 10) CB. (f) Sorted CD14 monocytes from healthy (n 7) or HBV-exposed (n 8) CB were incubated with allogeneic CFSE-labelled

CD3T cells (E:T ratio 1) for 7 days and CFSE staining analysed using ow cytometry. T-cell proliferation index was calculated using Flowjo. Horizontal line in dot plots represents the median. P-values in cf were calculated using MannWhitney test, one-tailed. *Po0.05, ****Po0.0001.

The expression of some of these cytokines (that is, constitutively lower levels of pro-inammatory cytokines IL-6, IL-8 and TNF-a, and the chemokines CCL3 and CCL4) was validated at the protein level in the supernatant of ex vivo-sorted monocytes (Supplementary Fig. 5). Direct ex vivo production of IL-12p40 or IFN-a2 was not detectable (Supplementary Fig. 5), but after activation with TLR8 agonist (ssRNA40)13 the production of IL-12p40 was markedly upregulated and was signicantly higher in HBV-exposed CB monocytes than in controls (Fig. 2d).

Ex vivo phenotypic analysis conrmed the maturation and activation status of HBV-exposed CB monocytes. The levels of HLA-DR (HLA-class II presentation) and costimulation markers (CD40, CD80 and CD86) were signicantly higher in HBV-exposed CB monocytes than in controls (Fig. 2e). Functionally, HBV-exposed CB monocytes induced a higher level of proliferation of allogeneic peripheral blood mononuclear cells than healthy CB monocytes (Fig. 2f).

In addition to monocytes, we have also analysed other components of innate immunity with anti-viral properties, including CD123 plasmacytoid dendritic cells (pDCs) and natural killer (NK) cells (see Supplementary Table 1 for list of tested subjects). HBV-exposed CB pDCs were more activated than controls, characterized by signicantly higher mRNA expression of several ISGs (Supplementary Fig. 6a) and higher production of IFN-a2 after stimulation with TLR9 agonist

(CpG ODN2216; Supplementary Fig. 6b). There were no signicant differences in the frequencies of NK subsets between healthy and HBV-exposed CB (Supplementary Fig. 7a). However, HBV-exposed CB NK cells displayed a more activated prole, as shown by increased frequencies and expression of TNF-related apoptosis-inducing ligand (means.e.m. in percentages; CD56br: healthy 4.71.5, HBV 16.95.6; CD56dim: healthy 0.20.1, HBV 0.80.3) and the activation marker CD69 (means.e.m. in percentages; CD56dim: healthy 13.51, HBV 18.11.2). HBV-exposed CB NK cells also had increased production of IFN-g after incubation with recombinant IL-12p70 and IL-18 compared with healthy controls (means.e.m. in pg ml 1; healthy 651.5414.8, HBV 3,4771,464) (Supplementary Fig. 7bd).

HBV exposure in utero induces robust Th1-polarized response. Newborn T cells produce IL-8 but are defective in Th1 cytokine production11. As IL-12p40 has been shown to increase IFN-g production in adult T cells, we analysed the ability of CB T cells to produce Th1 and other important T-cell cytokines (that is, IL-17, IL-21 and IL-22).

Figure 3a shows the frequency of CB CD3 T cells producing the indicated cytokines after polyclonal stimulation, in comparison with CD3 T cells present in healthy or HBV-infected young adults (1230 years). As expected, both HBV-exposed and

4 NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588 ARTICLE

IFN-

IL-2

TNF- MIP-1 IL-8

100

60 * *

0 HCCord blood Young adults peripheral blood

HBV HC HBV HC

Cord blood Young adults peripheral blood

HBV HC HBV HC

Cord blood Young adults peripheral blood

HBV HC HBV HC

Cord blood Young adults peripheral blood

HBV HC HBV HC

Cord blood Young adults peripheral blood

HBV HC HBV

% T cells

IL-4

IL-10 IL-17a IL-21 IL-22

2.0

1.5

1.0

1.5

0.8

0.6

1.0

0.6

1.0

0.4

0.5

0.2

0.0

HBV HC HBV HC

Cord blood Young adults peripheral blood

HBV HC HBV HC

Cord blood Young adults peripheral blood

HBV HC HBV HC

Cord blood Young adults peripheral blood

HBV

HC HBV HC

Cord blood Young adults peripheral blood

HBV HC

HBV

HCCord blood

Young adults peripheral blood

P=0.057

304

0 10 10 2,789 10

304

10 2,789 10

Healthy

HBV

% T-bet+ cells

304

304 10

TNF-

IFN-

Th1 cytokine

production pattern

Single producers Double producers

Triple producers

25.0 6.02.0 1.0

Healthy

HBV

Healthy

HBV

304

0 10 10 2,789 10

304

10 2,789 10

73.1 6.2

304

CD4+ CD8+

304 10

IFN- IL-2 IL-2

Figure 3 | HBV exposure in utero induces a robust Th1-polarized response in the CB. (a) CB mononuclear cells were stimulated overnight with phorbol myristate acetate (PMA)/ionomycin and the cytokine production by CD3 T cells was measured using intracellular cytokine staining. Dot plots show the percentages of cytokine-producing CD3 Tcells from healthy (HC; n 6) or HBV-exposed (HBV; n 11) CB. Cytokine production by CD3 Tcells

from the peripheral blood of pediatric and young adult patients with chronic HBV (HBV; n 10) and age-matched healthy controls (HC; n 33) were

included for comparison. Horizontal line represents the median. (b) Representative FACS dot plots of Th1 cytokine (TNF-a, IFN-g and IL-2) production from healthy and HBV-exposed CB T cells after PMA/ionomycin stimulation. (c) Graphical representation of single-, double- and triple-producer Th1 cells and their respective percentages in means.e.m. in HBV-exposed CB. (d) Percentage of T cells expressing the Th1 marker, T-bet, in CB of healthy (n 4) and

HBV (n 4) mothers. P-values were calculated using MannWhitney test.*Po0.05.

healthy CB T cells produced higher levels IL-8 but lower levels of IFN-g, IL-2 and TNF-a, compared with young adults T cells. The ability to produce IL-8 was similar in HBV-exposed CB T cells compared with controls, while a signicantly higher frequency of T cells producing Th1 cytokines was detected in HBV-exposed CB (means.e.m. in percentages; IFN-g: 2.40.4 versus1.10.3; IL-2: 10.22.8 versus 1.60.2; TNF-a: 5.80.9 versus2.20.5). A representative uorescence-activated cell sorting (FACS) dot plot of Th1 cytokine production by CB T cells is shown in Fig. 3b. Analysis of the Th1 (IFN-g, IL-2 and TNF-a)

double- and triple-producer T cells showed that B25% of HBV-exposed CB Th1 T cells were polyfunctional (means.e.m. in percentages; single: 73.16.2, double: 256, triple: 21; Fig. 3c).

The increased Th1 maturation in HBV-exposed CB was conrmed by direct ex vivo analysis of T cells expressing T-bet, the transcriptional regulator of Th1 differentiation (Fig. 3d). No differences were found between CB T cells of HBV-exposed or healthy controls in their ability to produce IL-17, IL-22 and IL-21 (Fig. 3a), even though decreased IL-21 production has been implicated in HBV vertical infection and chronicity22.

Despite having a more Th1-polarized response, HBV-exposed neonates do not seem to harbour any HBV-specic T cells.

Various attempts to detect HBV-specic T cells in HBV-exposed CB were unsuccessful. CB cells were analysed directly ex vivo with HBV-specic HLA tetramers or after in vitro expansion with peptides covering the whole HBV proteome. However, we were not able to detect any clear population of HBV-specic T cells in the CB of HBV-exposed neonates (Supplementary Fig. 8).

HBV exposure in utero triggers a state of trained immunity. We next analysed whether the enhanced immune maturation detected in HBV-exposed CB could result in a better ability of the neonatal immune cells to respond to unrelated pathogens.

We tested CB mononuclear cells against Pseudomonas aeruginosa, a bacteria that can cause severe infections in underweight neonates23, as well as other bacteria known to be involved in neonatal sepsis in the clinics, such as uropathogenic Escherichia coli (UPEC), Salmonella typhimurium, Acinetobacter baumanii and Listeria monocytogenes. Cytokine production in the supernatant was measured after 18 h of bacteria stimulation and we detected a strong Th1 cytokine signature (IFN-g, IL-12p40 and TNF-a) in bacterial-stimulated HBV-exposed CB compared with healthy controls (Fig. 4). Specically, the production of IFN-g was increased signicantly when HBV-exposed CB cells

NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 5

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588

IFN-

300

250 200 150

100

500

400

300

200

100

Healthy

HBV

Healthy

HBV

Healthy

pg ml1 pg ml 1 pg ml 1

P.aeruginosa

UPEC

S.typhimurium

A.baumanii

L.monocytogenes

IL-12p40

TNF-

P.aeruginosa

UPEC

S.typhimurium

A.baumanii

L.monocytogenes

12,000

8,000

4,000

HBV

P.aeruginosa

UPEC

S.typhimurium

A.baumanii

L.monocytogenes

Figure 4 | HBV exposure in utero triggers a state of trained immunity against unrelated bacterial challenge. CB mononuclear cells from healthy (n 3) or HBV (n 3) mothers were incubated with the bacteria

P. aeruginosa, UPEC, S. typhimurium, A. baumanii or L. monocytogenes (multiplicity of infection (MOI) 1) for 18 h and the cytokine production in the supernatant was analysed using multiplex assay. Bar graphs show the means.e.m. of each data set. P-values were calculated using two-way analysis of variance and multiple comparisons were done using uncorrected Fishers least signicant difference test. *Po0.05 and **Po0.01.

were challenged with UPEC, IL-12p40 production was signicantly higher after exposure to P. aeruginosa, UPEC andL. monocytogenes, and TNF-a production was signicantly elevated on exposure to UPEC, A. baumanii andL. monocytogenes, compared with controls. Similar trend for

higher production of Th1 cytokines was observed after exposure to S. typhimurium. Therefore, our data demonstrates that HBV exposure in utero increased the nonspecic production of Th1 cytokines towards unrelated pathogen challenge in vitro.

HBV-induced immunological changes are neonatal in origin. The increased immune maturation state detected in HBV-exposed CB cells could be due to either functional changes of neonatal monocytes/T cells or increased frequency of maternal immune cells in HBV-exposed CB. Immune cells of the mother are known to cross the placenta24, but whether HBV infection might have an effect on the degree of CB micro-chimerism is not known. We therefore quantied the frequency of maternal cells in HBV-exposed CB using two alternative methods. We rst used uorescence in situ hybridization (FISH) to quantify the number of maternal cells (expressing XX chromosomes) among bulk cells or sorted cells (CD14 monocytes or CD3 T cells) from healthy and HBV-exposed CB of male neonates (n 2 per group). No

signicant differences in the frequencies of maternal cells between HBV-exposed and healthy CB were detected (Fig. 5a,b). The mean frequencies of maternal cells in healthy and HBV-exposed CB, respectively, were 0.52% versus 0.75% (bulk), 0.64% versus 1% (CD3 T cells) and 0.49% versus 0.5% (CD14 monocytes;

Fig. 5a).

We then used quantitative PCR on single cells to measure the expression of genes selectively expressed only by maternal (female) cells (XIST long noncoding RNA)25 or male neonates (XKRY and TTY1 genes)26 as an alternative method to conrm that HBV-exposed CB was not preferentially enriched with maternal cells. A total of 136 CD14 cells from one HBV-exposed CB male neonate were analysed and we did not detect any maternal cells (0/136; Fig. 5c). This gave us a frequency of maternal cell in CD14 monocytes of HBV-exposed CB to be o0.7%, which is in line with the data obtained with FISH analysis (Fig. 5a) and with the reported frequency of maternal cells in healthy CB27. These results demonstrate that the immunological changes observed in HBV-exposed CB is unlikely to be due to an increase in maternal cell contamination, but probably due to genuine maturation of the neonatal immune cells.

HBV-induced immune maturation is associated with HBsAg. Conventionally, prenatal HBV infection is thought to occur in a minority of cases, as HBV-DNA, a sign of active HBV replication, is only detected in the CB of a few HBeAg mothers28. On the other hand, HBV can translocate efciently through intact trophoblastic barrier at early gestation29, but as the liver develops only after 12 weeks of gestation30 HBV infection and replication in hepatocytes might not occur.

To better understand the mechanisms responsible for the functional maturation of the immune cells present in the CB of neonates born to HBV mothers, we tested whether HBV or

HBV products can be traced in their CB plasma or mononuclear cells. HBV-DNA was detected in only two of the four CB plasma of neonates born to HBeAg mothers (Supplementary Table 1)

and was undetected in all the other CB plasma of HBeAg mothers. In addition, we were unable to detect the presence of

HBV-DNA in the CB mononuclear cells from healthy (n 2),

HBeAg (n 2) and HBeAg (n 1) mothers (Supplementary

Table 1), despite the latter being tested positive for HBV-DNA in the CB plasma.

However, as in woodchuck HBV model the woodchuck HBV can persist selectively in the blood of offspring of animals with very low level of viral replication31, we used immunouorescence32 to test whether HBV or HBV products can be found in populations of puried CB immune cells.

6 NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588 ARTICLE

Unfractionated

NS NS NS

CD14

CD3

2.0

1.5

1.0

0.5

0.0

2.0

Percentage of

maternal cell

Percentage of

maternal cell

2.5

1.5

1.0

0.5

0.0

Percentage of

maternal cell

1.5

1.0

0.5

0.0

HBV

Healthy HBV

Healthy

CD3

HBV Healthy HBV

XKRY

TTY1

XIST

F F HBV HBV

Expression

High

Low

M M

10 cells

10 cells 1 cell

1 cell

10 cells

1 cell

Figure 5 | HBV-induced immune cell maturation is neonatal in origin. (a) FISH analysis with X- and Y-chromosome-specic probes to detect maternal cells in male CB. Graphs show the percentages of maternal cells (means.e.m.) in CB unfractionated and fractionated cells (n 2 per group). Statistical

signicance between groups was calculated using MannWhitney test, one-tailed. P-value o0.05 is considered statistically signicant. NS denotes nonsignicant. (b) Representative FISH images from each sorted cell population in healthy and HBV-exposed CB. Nuclei were counterstained with DAPI (blue), X- and Y-chromosomes in green and red, respectively. Maternal cells (white arrow) contain green chromosome X signals and no Ysignals. Scale bar, 5 mm. (c) Quantitative PCR analysis using 48:48 Dynamic Arrays (Biomark System-Fluidigm) of CD14 single cells derived from HBV-exposed CB of male neonate. Two male (M)-specic genes (XKRY and TTY1) are expressed in CB cells and not in female (F) cells. Similarly, XISTgene is selectively expressed in female cells. Black, no detected expression.

+rHBsAg

Healthy

HBV

1.0

0.8

% HBsAg+ cells/

DAPI+ cells

0.6

0.4

0.2

0.0

Healthy

HBV

Figure 6 | HBV-induced immune cell maturation is associated with the presence of HBsAg. (a) CD2 cells were enriched from CB using MACS beads and the presence of HBsAg was detected using immunouorescent staining. Detection of HBsAg in CB cells (white arrow) from healthy and HBV mothers (greenHBsAg; blueDAPI). Images are representative of seven CB samples per group. CB cells incubated with recombinant HBsAg was used as positive control. Scale bar, 50 mm. (b) Percentage of HBsAg cells among DAPI cells in healthy and HBV-exposed CB (n 7 per group). P-value

was calculated using MannWhitney test. **Po0.01.

NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 7

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588

We puried CB CD2 cells (enriched for APCs), stained them for hepatitis B surface antigen (HBsAg) and the number of

HBsAg cells was then quantied in ten random elds at 20

magnication (Fig. 6a). Despite most of the neonatal plasma of HBV mothers were negative for HBV-DNA, HBsAg cells were detectable in CD2 cells (APC-enriched cells) but not in

CD2 (T and NK) cells at a mean frequency of 0.60.2% (Fig. 6b). No positive immunostaining for HBsAg was detected in healthy CB (Fig. 6a,b).

Thus, despite their low quantity, the presence of HBsAg cells in the CB of neonates of HBV mothers indicates that their immune system has been in contact with the virus or viral products before birth.

IL-12p40 and IFN-a2 induce CB immune cell maturation. The low frequency of HBsAg immune cells detected in the CB of

HBV-exposed neonates suggests that it is unlikely that HBV antigens can directly cause the maturation of monocytes in HBV-exposed CB. We hypothesize that the altered cytokine environment detected in the CB plasma of HBV-exposed neonates could be responsible for the induction of monocyte/ T-cell maturation.

Thus, to mimic the altered cytokine environment, we incubated CB cells from healthy mothers (n 3) overnight with

different concentrations of recombinant human (rh) IFN-a2(0.00044 ng ml 1) and rhIL-12p40 (0.11,000 ng ml 1), alone or in combination, and analysed the activation of T cells and monocytes by ow cytometry. The data for one representative CB sample is shown in Fig. 7a,b. Specically, rhIFN-a2 alone (4 ng ml 1) was able to promote Th1 development and monocyte maturation of healthy CB cells compared with no

cytokine controls, while high dose of rhIL-12p40 alone (1,000 ng ml 1) had modest effects. However, a combination of both rhIFN-a2 (4 ng ml 1) and rhIL-12p40 (1,000 ng ml 1)

further increased the frequency of T-bet expressing CD4 and CD8 T cells than either rhIFN-a2 or rIL-12p40 alone. At lower doses of rhIL-12p40 (110 ng ml 1), in combination with high dose of rhIFN-a2 (4 ng ml 1), the median uorescence intensity of HLA-DR, CD40 and CD80/CD86 on CB monocytes was upregulated compared with using both cytokines at high doses (mean median uorescence intensity; 1 ng ml 1 rhIL-12p40;

HLA-DR, 5,542 versus 5,294; CD40, 276 versus 235; CD80/CD86, 21,623 versus 19,571). There was a clear dose effect for rhIFN-a2 in Th1 development (with xed concentration of rhIL-12p40 at 1,000 ng ml 1) and this effect was abolished at 0.004 ng ml 1 of rhIFN-a2. For rhIL-12p40, there was a trend for increased monocyte activation with decreasing rhIL-12p40 (with xed concentration of rhIFN-a2 at 4 ng ml 1) and this effect peaked at

B1 ng ml 1 of rhIL-12p40. Most importantly, the increase in T-bet T cells and the enhanced activation of monocytes were observed when CB cells (n 2) were incubated with rhIFN-a2

and rhIL-12p40 at concentrations observed in the HBV-exposed CB plasma (rhIFN-a20.4 ng ml 1 and rhIL-12p400.1 ng ml 1;

Fig. 7c).

DiscussionThe concept of trained innate immune responses has been documented in plants33,34, invertebrates3537, mice3840 and, more recently, in vaccinated humans41. However, no such evidence has been demonstrated so far in newborns during the course of a natural viral infection. In this work, we demonstrated that HBV exposure in utero induces a state of trained immunity

CD4+ T cells

CD8+ T cells

Decreasing IL-12p40

Decreasing IFN-2

% T-bet+

80 60 403

% T-bet+

18 16 144

IFN-2 (ng ml ,4)

IFN-2 (ng ml ,4) IL-12p40 (ng ml )

10 10 10 10 10 10 10 10 10 10

10 10

10 10 10 10 10 10 10 10

PMA/

lono

10 10 10 10 10 10 10 10 10 10

10 10

10 10 10 10 10 10 10 10

PMA/

lono

IL-12p40 (ng ml )

HLA-DR

CD4+ T cells

#1#2 #1

#1 #1

CD40 CD80/86

6,000

Decreasing IL-12p40

Decreasing IFN-2

Decreasing IL-12p40

Decreasing IFN-2

Decreasing IL-12p40

Decreasing IFN-2

Decreasing IL-12p40

Decreasing IFN-2

30,000

5,500

5,000

MFI

4,500

300

200

20,000

MFI

4,000

MFI

100

10,000

3,500 IFN-2 (ng ml ,4)

10 10 10 10 10 10 10 10 10 1010 10

10 10 10 10 10 10 10 10

LPS

IFN-2 (ng ml ,4) IFN-2 (ng ml ,4) IL-12p40 (ng ml ) IL-12p40 (ng ml )

10 10 10 10 10 10 10 10 10 10

10 10

10 10 10 10 10 10 10 10

LPS

10 10 10 10 10 10 10 10 10 10

10 10

10 10 10 10 10 10 10 10

LPS

IL-12p40 (ng ml )

CD8+ T cells HLA-DR CD40 CD80/86

6,000

1.5

1.0

0.5

0.0 0

400

200

% T-bet+

4,000

20,000

15,000

10,000

5,000

300

MFI

#2 #2

2,000

100

Unstimulated

Stimulated

Unstimulated

Stimulated

Unstimulated

Stimulated

Unstimulated

Stimulated

Unstimulated

Stimulated

Figure 7 | IL-12p40 and IFN-a2 trigger the maturation of healthy CB immune cells in vitro. CB mononuclear cells from healthy mothers (n 3)

were incubated with rhIL-12p40 or rhIFN-a2, either alone or in different combinations of concentrations, overnight and the activation phenotypes of T cells and monocytes were analysed by FACS. Graphs (a,b) show the data from one representative sample. Dotted lines indicate the basal level without any cytokine stimulation. (a) The percentage of T-bet cells in CD4 and CD8 CB T cells. (b) The median uorescence intensity (MFI)

of expression of HLA-DR, CD40 and CD80/CD86 on CB monocytes. (c) The activation phenotypes of T cells and monocytes in CB cells (n 2,

denoted 1 and 2) stimulated with physiological concentrations of rhIL-12p40 (0.1 ng ml 1) and rhIFN-a2 (0.4 ng ml 1).

8 NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588 ARTICLE

characterized by enhanced innate immune cell maturation and increased Th1 development. Importantly, this immune system maturation results in a better ability of the neonatal immune cells to respond to unrelated pathogen exposure.

Additional immunological changes observed in HBV-exposed neonates were the higher production of IL-12p40 and lower production of IL-10 and pro-inammatory cytokines (IL-6, IL-8 and TNF-a) in the CB plasma than controls. This immunological pattern (high Th1-related/low IL-10 and pro-inammatory cytokines) was also observed in HBV-exposed CB monocytes. Therefore, HBV exposure in utero induced complex changes in the newborns immune system that were not exclusively stimulatory in nature but were generally compatible with an advanced immune maturation state. Indeed, during the rst year of life12, the infants immune system does not only acquire a more pronounced Th1 T-cell prole but also decrease its ability to produce IL-10 and pro-inammatory cytokines.

A further alteration induced by HBV exposure was the detection of higher levels of IFN-a2 that were only statistically signicant in the CB plasma of Asian but not Caucasian HBV mothers. Whether such differences could be explained by different HBV genotypes infecting the two cohorts (HBV genotypes B/C in Asian patients versus HBV genotype D in Caucasian patients) will require further analysis.

Epidemiological, clinical and experimental evidences have already raised doubts about the concept of immunological tolerance during HBV infection42. Indeed, our data show that HBV, a virus thought to exploit the immaturity of the neonatal immune system to establish chronic infection, was unexpectedly inducing a state of trained immunity with a more pronounced Th1 prole. However, in contrast to the evidences of global immune system maturation, we were not able to detect any HBV-specic T-cell response in the CB of HBV-exposed neonates. This is in contrast to the data obtained in human cytomegalovirus43 and human immunodeciency virus infections44, where virus-specic T cells can be detected in neonates. A possible scenario is that HBV has evolved a special relationship with its human host: although the defective priming of HBV-specic T cells can predispose to HBV chronicity, the induction of a trained immunity prole with a skewed Th1 response and suppression of pro-inammatory events might have the advantage of decreasing mortality from exposure to unrelated pathogens.

Nonetheless, more data need to be gathered to fully understand the impact of vertical HBV infection on its host. A limitation of our study is that as HBV-exposed neonates must be vaccinated and treated within 24 h of birth, we were unable to investigate the consequences of the establishment of a persistent HBV infection after birth. It could be possible that the establishment of chronic HBV infection in neonates may be associated with a more robust and persistent Th1 response and a better ability to control unrelated pathogens, or it may be associated with defects in the priming of adaptive immunity, as shown in HBV-transgenic mice6. We posit that the evidences of trained immunity shown here are more in line with our recent demonstration that young CHB-infected patients present a fully normal Th1 T-cell prole and do not show any increased defects in HBV-specic T-cell repertoire compared with HBV-infected adults10, but certainly a more precise evaluation of the immunological events that are occurring in the early phases of HBV infection is needed.

The question of how HBV exposure is inducing trained immunity is still open. The low frequency of HBsAg monocytes detected in the CB of HBV-exposed neonates does not support the scenario of a direct HBV infection of the neonates triggering trained immunity. It is perhaps more likely to be that the cause of induction of trained immunity lies with the cytokine environment detected in the HBV-exposed newborns, characterized by an

increase production of IL-12p40 and, at least in some cases, IFN-a2. Both IL-12p40 and IFN-a2 have been shown to skew T-cell development towards Th1 maturation19,4547, and incubation of CB cells with these recombinant cytokines in our in vitro study supports such a possibility. Epigenetic-mediated functional reprogramming of immune cells has been reported as one of the mechanisms mediating trained immunity41, but whether such epigenetic events are occurring in HBV-exposed neonates requires further investigations. Certainly, our in vitro assays are a profound approximation of the events that are occurring during the natural development of the newborn immune system and a clear answer to this question will probably require the use of the woodchuck hepatitis B animal model wherein viral transmission from mother to offspring can occur even in the presence of extremely low quantity of virus31.

The source of IL-12p40, the cytokine that was found to be consistently elevated in the CB plasma of HBV-exposed neonates, is also at the moment unknown. Ex vivo production of IL-12p40 in sorted monocytes from HBV-exposed CB was not detectable, suggesting that despite the natural contact with HBV products, the circulating monocytes were not directly responsible for this cytokine production. A possibility is that the high levels of IL-12p40 detected in the HBV-exposed CB may be produced by other types of haematopoietic phagocytic cells, such as myeloid DCs or neutrophils. Alternatively, the placenta, which consists of multiple layers of cell barriers with precise immune function and has been shown to harbour HBV and HBV products48, might actually be the source of IL-12p40 production in response to HBV. Pregnancy is known to modulate the natural history of HBV infection, but whether placental cells can actually play a direct role in the modulation of maternal or neonatal infections remains unknown.

Despite these limitations, our data clearly show a novel interaction between HBV and its human host. The evidences of immune system maturation in the newborns as a result of HBV exposure in utero suggests the presence of a symbiotic relationship between HBV and humans, similar to that demonstrated in mice with persistent herpes simplex virus infection49. This symbiotic hostvirus interaction could be the explanation as to why HBV has been so efcient in co-existing in a large part of the human population from its dawn50.

Methods

Patients and blood samples. Umbilical CB was obtained from two independent cohort of patients: the rst cohort consists of 20 neonates born to HBV-seropositive women (HBV-exposed group) and 7 neonates born to HBV-seronegative women (non-exposed control group). The deliveries occurred at the National University Hospital, Singapore, and all women were of Asian ethnicity (Chinese or Malay). The second cohort consists of eight neonates born to HBV women and four neonates born to HBV women. The deliveries occurred at the Dipartimento

Materno Infantile, Azienda Ospedaliero Universitaria di Parma, Italy, and the women were of Caucasian ethnicity. None of the HBV-infected mothers in both cohorts received antiviral treatment before delivery. Basic clinical and demographic data were collected at the time of delivery (Supplementary Table 1). Maternal serum was tested for HBsAg, HBeAg and HBV DNA level (a few patients). All mothers in the HBV group were positive for HBsAg and negative for human immunodeciency virus. At delivery, CB was collected from the umbilical vein using a direct dripping method into tubes containing heparin. Subsequently, plasma was separated from whole blood and stored at 20 C and CB mono-

nuclear cells were isolated by density-gradient centrifugation on Ficoll-Hypaque. The study in Singapore was approved by the Domain Specic Review Board at National University Hospital, which was in accordance with the guidelines of the Singapore National Healthcare Group. The study in Italy was approved by the Comitato Etico Azienda Ospedaliero Parma (Protocol 6274) and was in accordance with the guidelines of the Italian Minister of Health. Blood samples from 10 pediatric and young adult CHB patients (1230 years old) and 33 age-matched healthy controls used for the Th1 T-cell analysis were obtained from a viral hepatitis clinic at The Royal London Hospital, UK. Ethics approval was obtained from Barts and The London NHS Trust Ethics Review Board. All donors gave written informed consent.

NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 9

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588

Antibodies and reagents. Monoclonal anibodies (mAbs) of anti-human-CD3-eFluor 605NC (clone OKT3, 3:100), anti-CD4-eFluor 650NC (RPA-T4, 3:100), anti-CD7-FITC (4H9, 2.5:100), anti-CD11c eFluor 450 (3.9, 1.25:100), anti-HLA-DRAlexa Fluor 700 (LN3, 5:100) or eFluor 605NC (LN3, 2:100) and anti-T-bet (eBio4B10, 1:100) were obtained from eBioscience (San Diego, CA). Anti-CD3-FITC (HIT3a, 2.5:100), anti-CD11b-PE-Cy7 (ICRF44, 5:100), anti-CD16-APC-Cy7 (3G8, 2.5:100) or BV711 (3G8, 5:100), anti-CD19-FITC (HIB19, 2.5:100), anti-CD20-FITC (2H7, 2.5:100), anti-CD56-FITC (HCD56, 2.5:100), anti-CD86-APC (IT2.2, 6:100) and anti-CD123-PerCP-Cy5.5 (6H6, 2.5:100) were obtained from Biolegend (San Diego, CA). Anti-CD3-PE-Cy7 (SK7, 2:100), anti-CD8-V500 (RPA-T8, 1:100), anti-CD11c-V450 (B-Ly6, 1.25:100), anti-CD14-PE-Cy7 (M5E2,2.5:100), anti-IL17a-V450 (N49-653, 4:100), anti-CD40-Alexa Fluor 700 (5C3, 6:100), anti-CD45-V500 (HI30, 2:100), anti-CD56-V450 (B159, 2:100), anti-CD80-PE (L307.4, 6:100), anti-IFNg-V450 (B27, 6:100) or -PerCP-Cy5.5 (B27, 6:100), anti-IL-2-PerCP-Cy5.5 (MQ1-17H12, 4:100), anti-IL-4-FITC (MP4-25D2, 4:100), anti-IL-8-PE (G265-8, 2:100), anti-IL-10-APC (JES3-19F1, 6:100), anti-IL-21-PE (3A3-N2.1, 6:100), anti-MIP-1b-PE-Cy7 (D21-1351, 4:100), anti-TNF-related apoptosis-inducing ligand-PE (RIK-2, 6:100) and anti-TNF-a-PE-Cy7 (MAb11, 6:100) were obtained from Becton Dickinson (BD, San Jose, CA). mAbs of anti-IL-22-APC (142928, 10:100) and anti-MIP-1a-FITC (93342, 4:100) were obtained from R&D Systems (Minneapolis, MN). mAbs of anti-CD3-eFluor 605NC (UCHT1, 6:100) was obtained from Molecular Probes (Carlsbad, CA). mAb of anti-CD14-ECD (RMO52, 2.5:100) was obtained from Beckman Coulter (Brea, CA). Live/Dead Fixable Dead Cell Stain Kits (yellow and aqua, 1:1,000 in 1 PBS) were

obtained from Invitrogen. Agonists for human TLR4 (E. coli K12 LPS, 1 mg ml 1), TLR8 (ssRNA40, 1 mg ml 1) and TLR9 (CpG ODN2216, 5 mM) were obtained from

Invivogen (San Diego, CA). Phorbol myristate acetate (2 ng ml 1) and ionomycin (1 mg ml 1) were obtained from Sigma-Aldrich (Saint Louis, Missouri).

HBV DNA detection. HBV DNA was isolated from CB plasma or CB mono-nuclear cell lysates using the High Pure Viral Nucleic Acid Kit (Roche Applied Science). For the CB mononuclear cells, the cells were lysed in RLT buffer (Qiagen) and the lysate was passed through a blunt 20-gauge needle (0.9 mm diameter) tted to an RNase-free syringe. The lysate was centrifuged and the supernatant collected for HBV DNA extraction. Five microlitres of internal control (HBV RG/TM IC) from the Artus HBV RG PCR kit (Qiagen) was added to the mixture of sample material and lysis buffer to control for the purication process. HBV DNA was quantied using the Artus HBV RG PCR kit (Qiagen) on a Rotor-Gene Q platform, according the manufacturers protocol. The 95% HBV DNA detection limit of the assay was 20 IU ml 1 or 108 copies per ml.

HBsAg detection by immunouorescence. CD2 cells (non-T non-NK cells) were negatively isolated using CD2 microbeads (Miltenyi Biotec), according to manufacturers protocol. Subsequently, CD2 cells were incubated for 2 h with or without recombinant HBsAg (10 mg ml 1; adr subtype) at 37 C incubator and antigen uptake was stopped by two times cold wash in PBS. Cells were xed and stained for HBsAg, using a two-step biotinstrepavidin staining protocol as previously described32. Cells were cytospinned onto Superfrost Plus slides (Thermo Scientic) using CYTO-TEK Cytocentrifuge (Sakura Finetek), sealed with ProLong Gold Antifade Reagent with DAPI (4,6-diamidino-2-phenylindole; Invitrogen) and HBsAg staining was visualized using TissueFAXS system (TissueGnostics). The exposure time for uorescein isothiocyanate (FITC) lter (for HBsAg staining) on the microscope was adjusted based on the negative controls (healthy CB cells) and positive controls (healthy CB cells incubated with recombinant HBsAg), to minimize autouorescence/background staining without compromising signal. The total number of HBsAg cells and the total number of DAPI-stained nuclei were manually counted in ten random high power elds ( 20 magnication).

Immunophenotyping. CB mononuclear cells were washed in PBS and stained with Live/Dead Fixable Dead Cell Stain. The cells were then washed in staining buffer (PBS, 1% BSA (Roche, Basel, Switzerland) and 0.1% sodium azide (Sigma-Aldrich)), stained for expressed cell surface molecules and analysed on a BD FACSAria or LSR II cytometer. T-bet staining for Th1 cells was performed using Human FoxP3 Buffer Set (BD), according to manufacturers protocol. Following overnight stimulation with phorbol myristate acetate (2 ng ml 1) and ionomycin (1 mg ml 1) in the presence of brefeldin A (2 mg ml 1), surface-stained cells were xed and permeabilized (Cytox/Cytoperm; BD) before being stained for produced cytokines. Cells were then washed in staining buffer with 0.1% saponin (Sigma-Aldrich) before acquisition on LSR II cytometer. Data were analysed using FACSDiva software (BD).

Cell sorting/gating strategy. APCs were sorted/gated based on lineage markers (CD3/CD7/CD56/CD19/CD20) and HLA-DR expression: CD14 monocytes (lineage HLA-DR CD14 CD16low) and pDCs (lineage HLA-DR CD14

CD16 CD11c CD123 ). T cells were gated based on CD3 expression.

Human immunology gene expression analysis. Cell lysates from 50,000 sorted CD14 monocytes/pDCs were analysed using the preassembled nCounter GX

Human Immunology Kit and the nCounter system (NanoString Technologies, Seattle, WA), according to the manufacturers instructions. Data analysis was performed as previously described51. Briey, a cutoff of two times the mean of the negative controls supplied in the kit was used to discriminate against nonspecic probe binding (noise). Samples were then normalized based on the geometric means of both the positive controls supplied in the kit and the panel of housekeeping genes, as recommended by the manufacturer. The coefcient of variation (s.d. of the normalized counts across all samples/mean normalized counts across all samples, expressed as a percentage) of each gene was calculated and the mean coefcient of variation of the housekeeping genes was used as a cutoff to lter out genes that remain stable across all samples analysed.

Clustering. Log2 normalized counts were used for clustering analysis. Data were normalized (mean centering of genes) and hierarchical clustering of genes was generated using Cluster 3.0 (similarity metric: Euclidean distance, clustering method: Average linkage) and visualized in TreeView.

Mixed lymphocyte reaction. Pan T cells (105 cells per well from a single healthy donor) were labelled with carboxyuorescein succinimidyl ester (CFSE) and seeded in 96-well round-bottom plate with sorted CD14 monocytes (ET 1). Pan T

cells incubated with anti-CD3/CD28-coupled beads (Invitrogen, 1:1 bead per cell ratio) were used as positive control. After 7 days, cells were stained with anti-CD3-Horizon V450 (BD Biosciences) and acquired on a BD LSR-II ow cytometer. T-cell proliferation was assessed by CFSE dilution. Proliferation index was calculated using Flowjo software.

Bacterial stimulation. CB mononuclear cells were seeded in 96-well U-bottom plate at 105 cells per well in AIM-V media (Life Technologies) supplemented with 2% AB serum (Invitrogen). The number of monocytes was assumed at 10% of total cells. P. aeruginosa, L. monocytogenes, UPEC, S. typhimurium and A. baumanii were added to the culture at a multiplicity of infection 1 per monocyte and incubated overnight. Cell supernatant was collected and analysed for cytokine production with the multiplex assay (Luminex).

Cytokine multiplex bead-based assay and ELISA. Cytokine concentrations in plasma samples and in supernatants of cultured cells were measured using MILLIPLEX MAP Human Cytokine/Chemokine Magnetic Bead PanelPremixed42 Plex (Millipore, Billerica, MA), according to manufacturers protocol. Analyte concentrations were determined by interpolation from a standard curve. ELISA of IL-12 and IL-23 (R&D Systems), as well as of IFN-b and IFN-l (PBL Assay

Science) were performed according to the manufacturers instructions.

Recombinant cytokine stimulation. Healthy CB cells were seeded in 96-well U-bottom plate at 2 105 cells per well in AIM-V media (Life Technologies)

supplemented with 2% AB serum (Invitrogen). rhIL-12p40 (BD) and/or rhIFN-a2 (PBL, Piscataway, NJ) were added either alone or in different combinations of concentrations for 24 h and the activation of T cells and monocytes analysed using FACS (BD). The concentrations of rhIL-12p40 tested were 0.11,000 ng ml 1 and0.00044 ng ml 1 for rhIFN-a2.

Nuclei preparation and FISH analysis. Nuclei were prepared for FISH analysis by resuspending the cells in 7 ml of 0.075 mol l 1 KCl and incubating them at 37 C water bath for 15 min. Two milliliters of 3:1 methanol:acetic acid was added to the cells, centrifuged and the pellet was resuspended and washed twice with 7 ml of methanol:acetic acid solution. Samples were stored at least overnight at 20 C

until slides were prepared. Nuclei were dropped onto methanol-cleaned slides and air dried overnight on a 56 C hot plate.

Slides pretreatment was performed in the following order: 1 PBS at room

temperature for 5 min, pepsin/HCl solution at 37 C for 5 min, 1 PBS at room

temperature for 5 min, 1% formaldehyde at room temperature for 10 min, 1 PBS

at room temperature for 5 min and dehydrated in successive washes of 70%, 80% and 100% ethanol at room temperature for 2 min each and allowed to air dry. Poseidon Chromosome X and Y Satellite Enumeration Probes were obtained from Kreatech (the Netherlands) and used according to manufacturers protocol. Nuclei were counterstained with DAPI solution. Post-hybridization washes were performed as per manufacturers instructions. Images were visualized and captured using the Isis Fluorescence Imaging System with the Nikon Eclipse 80i microscope. The number of maternal cells were manually counted in 20 random high-power elds and expressed as a percentage of total nuclei.

High-throughput single-cell quantitative PCR. Cells were rst sorted into5 ml lysis buffer in 96-well plates (CellsDirect Resuspension and Lysis Buffer, Invitrogen) and snap-frozen with dry ice. Right before reverse transcription, samples were heated at 65 C for 90 s and immediately snap chilled on ice for5 min. Reaction buffer (1.4 ml) and 0.7 ml enzyme (Maxima First Strand cDNA Synthesis Kit, Thermo Scientic) were added to each sample and reverse transcription was performed with the following protocol: 10 min 25 C, 15 min 50 C,

10 NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588 ARTICLE

5 min 85 C. Sequence-specic pre-amplication was performed using TaqMan PreAmp Master Mix (Invitrogen, PN 4391128) by activating the enzyme at 95 C for 10 min, denaturing at 96 C for 5 s, then annealing and amplication at 60 C for 4 min for 20 cycles. Unincorporated primers were inactivated by Exonuclease I by digesting at 37 C for 30 min and inactivation at 80 C for 15 min. The resulting complementary DNA was diluted vefold in DNA Suspension Buffer (10 mM Tris, pH 8.0, 0.1 mM EDTA; TEKnova, PN T0221) before analysis with 2 Sso Fast

EvaGreen Supermix With Low ROX (Bio-Rad Laboratories, PN 172-5211) with nested primers in 48:48 Dynamic Arrays on a Biomark System (Fluidigm).

Ct values were calculated from the systems software (Biomark Real-time PCR analysis, Fluidigm). The list of primers used is shown in Supplementary Methods.

Raw data treatment and visualization. All Raw Ct values were normalized to the assumed detection Ct level of 30, following recommendation from Fluidigm technical support. For visualization purposes, heatmaps were produced using custom scripts and ggplot package in R.

Statistical analysis. The non-parametric MannWhitney U-test was used to determine the statistical signicance of differences, unless otherwise stated, and P-values were denoted by *Po0.05, **Po0.01, ***Po0.001 and ****Po0.0001.

References

1. Adkins, B., Leclerc, C. & Marshall-Clarke, S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4, 553564 (2004).

2. Elahi, S. et al. Immunosuppressive CD71 erythroid cells compromise neonatal host defence against infection. Nature 504, 158162 (2013).

3. Liaw, Y. F. & Chu, C. M. Hepatitis B virus infection. Lancet 373, 582592 (2009).

4. Beasley, R. P. et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 2, 10991102 (1983).

5. Milich, D. R. et al. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl Acad. Sci. USA 87, 65996603 (1990).

6. Publicover, J. et al. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J. Clin. Invest. 123, 37283739 (2013).

7. Andrade, B. B. et al. Hepatitis B infection is associated with asymptomatic malaria in the Brazilian Amazon. PLoS ONE 6, e19841 (2011).

8. Oakley, M. S. et al. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.J. Immunol. 191, 46994708 (2013).9. Thursz, M. R. et al. Association of hepatitis B surface antigen carriage with severe malaria in Gambian children. Nat. Med. 1, 374375 (1995).

10. Kennedy, P. T. et al. Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B. Gastroenterology 143, 637645 (2012).

11. Gibbons, D. et al. Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants. Nat. Med. 20, 12061210 (2014).

12. Kollmann, T. R., Levy, O., Montgomery, R. R. & Goriely, S. Innate immune function by Toll-like receptors: distinct responses in newborns and the elderly. Immunity 37, 771783 (2012).

13. Levy, O., Suter, E. E., Miller, R. L. & Wessels, M. R. Unique efcacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood 108, 12841290 (2006).

14. Benn, C. S., Netea, M. G., Selin, L. K. & Aaby, P. A small jaba big effect: nonspecic immunomodulation by vaccines. Trends Immunol. 34, 431439 (2013).

15. Netea, M. G., Quintin, J. & van der Meer, J. W. Trained immunity: a memory for innate host defense. Cell Host Microbe 9, 355361 (2011).

16. Dunn, C. et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137, 12891300 (2009).17. Tan, A. T. et al. A longitudinal analysis of innate and adaptive immune prole during hepatic ares in chronic hepatitis B. J. Hepatol. 52, 330339 (2010).

18. Sato, S. et al. The RNA sensor RIG-I dually functions as an innate sensor and direct antiviral factor for hepatitis B virus. Immunity 42, 123132 (2015).

19. Cooper, A. M. & Khader, S. A. IL-12p40: an inherently agonistic cytokine. Trends Immunol. 28, 3338 (2007).

20. Lavoie, P. M. et al. Profound lack of interleukin (IL)-12/IL-23p40 in neonates born early in gestation is associated with an increased risk of sepsis. J. Infect. Dis. 202, 17541763 (2010).

21. Geiss, G. K. et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26, 317325 (2008).

22. Publicover, J. et al. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J. Clin. Invest. 121, 11541162 (2011).

23. Leigh, L., Stoll, B. J., Rahman, M. & McGowan, Jr. J. Pseudomonas aeruginosa infection in very low birth weight infants: a case-control study. Pediatr. Infect. Dis. J. 14, 367371 (1995).

24. Mold, J. E. et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 322, 15621565 (2008).

25. Brown, C. J. et al. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349, 3844 (1991).

26. Lau, Y. F. & Zhang, J. Expression analysis of thirty one Y chromosome genes in human prostate cancer. Mol. Carcinog. 27, 308321 (2000).

27. Hall, J. M. et al. Detection of maternal cells in human umbilical cord blood using uorescence in situ hybridization. Blood 86, 28292832 (1995).

28. Borgia, G., Carleo, M. A., Gaeta, G. B. & Gentile, I. Hepatitis B in pregnancy. World J. Gastroenterol. 18, 46774683 (2012).

29. Bhat, P. & Anderson, D. A. Hepatitis B virus translocates across a trophoblastic barrier. J. Virol. 81, 72007207 (2007).

30. Moore, K. & Persaud, T. The Developing Human: Clinically Oriented Embryology 7th edn (W. B. Saunders Company, 2003).

31. Cofn, C. S. & Michalak, T. I. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J. Clin. Invest. 104, 203212 (1999).

32. Gehring, A. J. et al. Mobilizing monocytes to cross-present circulating viral antigen in chronic infection. J. Clin. Invest. 123, 37663776 (2013).

33. Durrant, W. E. & Dong, X. Systemic acquired resistance. Annu. Rev. Phytopathol. 42, 185209 (2004).

34. Sticher, L., Mauch-Mani, B. & Metraux, J. P. Systemic acquired resistance. Annu. Rev. Phytopathol. 35, 235270 (1997).

35. Moret, Y. & Siva-Jothy, M. T. Adaptive innate immunity? Responsive-mode prophylaxis in the mealworm beetle, Tenebrio molitor. Proc. Biol. Sci. R. Soc. 270, 24752480 (2003).

36. Pham, L. N., Dionne, M. S., Shirasu-Hiza, M. & Schneider, D. S. A specic primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog. 3, e26 (2007).

37. Rodrigues, J., Brayner, F. A., Alves, L. C., Dixit, R. & Barillas-Mury, C. Hemocyte differentiation mediates innate immune memory in Anopheles gambiae mosquitoes. Science 329, 13531355 (2010).

38. Bistoni, F. et al. Evidence for macrophage-mediated protection against lethal Candida albicans infection. Infect. Immun. 51, 668674 (1986).

39. Sun, J. C., Beilke, J. N. & Lanier, L. L. Adaptive immune features of natural killer cells. Nature 457, 557561 (2009).

40. van t Wout, J. W., Poell, R. & van Furth, R. The role of BCG/PPD-activated macrophages in resistance against systemic candidiasis in mice. Scand. J. Immunol. 36, 713719 (1992).

41. Kleinnijenhuis, J. et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecic protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci. USA 109, 1753717542 (2012).

42. Bertoletti, A. & Kennedy, P. T. The immune tolerant phase of chronicHBV infection: new perspectives on an old concept. Cell. Mol. Immunol. 5, doi:10.1038/cmi.2014.79 (2014).

43. Marchant, A. et al. Mature CD8( ) T lymphocyte response to viral infection

during fetal life. J. Clin. Invest. 111, 17471755 (2003).44. Luzuriaga, K. et al. HIV-1-specic cytotoxic T lymphocyte responses in the rst year of life. J. Immunol. 154, 433443 (1995).

45. Brassard, D. L., Grace, M. J. & Bordens, R. W. Interferon-alpha as an immunotherapeutic protein. J. Leukoc. Biol. 71, 565581 (2002).

46. Nguyen, K. B. et al. Critical role for STAT4 activation by type 1 interferons in the interferon-gamma response to viral infection. Science 297, 20632066 (2002).

47. Pien, G. C., Nguyen, K. B., Malmgaard, L., Satoskar, A. R. & Biron, C. A.

A unique mechanism for innate cytokine promotion of T cell responses to viral infections. J. Immunol. 169, 58275837 (2002).

48. Yu, M. et al. Correlation between vertical transmission of hepatitis B virus and the expression of HBsAg in ovarian follicles and placenta. PLoS ONE 8, e54246 (2013).

49. Barton, E. S. et al. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 447, 326329 (2007).

50. Paraskevis, D. et al. Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology 57, 908916 (2013).

51. Tang, X. Z. et al. IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. J. Immunol. 190, 31423152 (2013).

Acknowledgements

We thank the subjects and their families for participating in this study, Patrick Kennedy for providing the young adult samples, Bindu Sukumaran for providing the bacteria strains, John Conolly and Kaiting Ng for invaluable technical help with the Nanostring assay, Komathi Paramasivam for assistance with the cell sorter and Veronica Khee for help with sample collection.

Authors contributions

M.H. designed the study, performed the experiments, analysed the data and wrote the manuscript. E.S. collected the samples, designed the study, performed the experiments

NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications 11

ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7588

and analysed the data. D.L. and A.J.G. performed the experiments and analysed the data. S.F., B.A., S.U. and Y.-S.C. provided the samples and proofread the manuscript. E.G. designed the study, analysed the data and proofread the manuscript. A.B. designed the study, analysed the data and wrote the manuscript.

Additional information

Accession codes: The Nanostring data reported in the paper have been deposited in the NCBI GEO database under accession number GSE65389.

Supplementary Information accompanies this paper at http://www.nature.com/naturecommunications

Web End =http://www.nature.com/ http://www.nature.com/naturecommunications

Web End =naturecommunications/

Competing nancial interests: The authors declare no competing nancial interests.

Reprints and permission information is available online at http://npg.nature.com/reprintsandpermissions

Web End =http://npg.nature.com/ http://npg.nature.com/reprintsandpermissions

Web End =reprintsandpermissions/

How to cite this article: Hong, M. et al. Trained immunity in newborn infants of HBV-infected mothers. Nat. Commun. 6:6588 doi: 10.1038/ncomms7588 (2015).

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the articles Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Web End =http://creativecommons.org/licenses/by/4.0/

12 NATURE COMMUNICATIONS | 6:6588 | DOI: 10.1038/ncomms7588 | http://www.nature.com/naturecommunications

Web End =www.nature.com/naturecommunications

Word count: 10742

Show less

Abstract

Translate

The newborn immune system is characterized by an impaired Th1-associated immune response. Hepatitis B virus (HBV) transmitted from infected mothers to newborns is thought to exploit the newborns' immune system immaturity by inducing a state of immune tolerance that facilitates HBV persistence. Contrary to this hypothesis, we demonstrate here that HBV exposure in utero triggers a state of trained immunity, characterized by innate immune cell maturation and Th1 development, which in turn enhances the ability of cord blood immune cells to respond to bacterial infection in vitro. These training effects are associated with an alteration of the cytokine environment characterized by low IL-10 and, in most cases, high IL-12p40 and IFN-α2. Our data uncover a potentially symbiotic relationship between HBV and its natural host, and highlight the plasticity of the fetal immune system following viral exposure in utero.

Details

Title

Trained immunity in newborn infants of HBV-infected mothers

Author

Hong, Michelle; Sandalova, Elena; Low, Diana; Gehring, Adam J; Fieni, Stefania; Amadei, Barbara; Urbani, Simonetta; Chong, Yap-seng; Guccione, Ernesto; Bertoletti, Antonio

Pages

6588

Publication year

2015

Publication date

Mar 2015

Publisher

Nature Publishing Group

e-ISSN

20411723

Source type

Scholarly Journal

Language of publication

English

DOI

https://doi.org/10.1038/ncomms7588

ProQuest document ID

1666292974

Trained immunity in newborn infants of HBV-infected mothers

Jump to:

Full Text

Abstract

Details

Suggested sources